UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Qualification
Date Qualified:
December 13, 2021 4:00 P.M.
Form:
1-A
CIK:
0000849636
Company Name:
RespireRx Pharmaceuticals Inc.
File Number:
024-11602